Buy Varun Beverages Ltd For Target Rs.1020 - ICICI Direct
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Splendid volume growth…
About the stock: Varun Beverages (VBL) is one of the largest franchisees of PepsiCo globally. The company produces & distributes carbonated drinks, juices & packaged drinking water in six countries including India. Some of the PepsiCo brands produced by VBL include Pepsi, Diet Pepsi, Seven-Up, Mirinda, Mountain Dew, Nimbooz, String, Slice, Tropicana, Aquafina among others.
* The company has operations in India (except Andhra Pradesh, J&K and Ladakh), Sri Lanka, Nepal, Morocco, Zambia and Zimbabwe
Q3CY21 Results: Varun Beverages reported strong volume growth of 28.4%
* Sales were up 33% YoY led by a strong recovery in volumes
* EBITDA was at | 494.7 crore, up 29.9% YoY, with margins at 20.6%
* Consequent PAT was at | 257.9 crore (up 59.7% YoY)
What should investors do? Varun Beverage share price has given 4.3x return (from | 195 in November 2016 to | 849 in October 2021).
* We revise our CY21 and CY22 numbers upwards with strong volume growth after the normalisation of mobility
* We maintain our BUY rating on the stock
Target Price and Valuation: We value the stock at | 1020, valuing the business at 23x CY23 EV/EBITDA
Key triggers for future price performance:
* With normalisation of mobility, full-fledged summer season after acquisition of south & west territories is likely to drive robust volume growth
* VBL has launched several new brands in last two years i.e. String, ‘Mountain Dew ICE’, milk based beverages. New products would aid revenues
* Given no major capex in the medium term, the company would be able to completely de-leverage its balance sheet in the next three to four years with strong free cash flow. Reduction in interest cost would boost profitability
Alternate Stock Idea: We like Zydus Wellness in our FMCG coverage.
* It is growing at a steady pace in nascent categories with a strong presence in health, nutrition space & margin expansion possibilities
* Trading at a significant discount to FMCG peers. BUY with TP of | 2,800
To Read Complete Report & Disclaimer Click Here
https://secure.icicidirect.com/Content/StaticData/Disclaimer.html
Above views are of the author and not of the website kindly read disclaimer
